Aliases & Classifications for Retinitis

MalaCards integrated aliases for Retinitis:

Name: Retinitis 12 55 15 73

Classifications:



External Ids:

Disease Ontology 12 DOID:3612
ICD10 33 H30.9
MeSH 44 D012173
NCIt 50 C115993
SNOMED-CT 68 35426003
UMLS 73 C0035333

Summaries for Retinitis

MalaCards based summary : Retinitis is related to retinitis pigmentosa 2 and retinitis pigmentosa 28. An important gene associated with Retinitis is RPGR (Retinitis Pigmentosa GTPase Regulator). The drugs Cidofovir and Ganciclovir have been mentioned in the context of this disorder. Affiliated tissues include eye, bone and retina, and related phenotypes are nervous system and vision/eye

Related Diseases for Retinitis

Diseases related to Retinitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1780)
# Related Disease Score Top Affiliating Genes
1 retinitis pigmentosa 2 33.9 RP2 RPGR
2 retinitis pigmentosa 28 33.7 FAM161A FLVCR1
3 retinitis pigmentosa 9 33.6 IMPDH1 RP9
4 retinitis pigmentosa 7 33.6 PRPH2 RHO RP9
5 retinitis pigmentosa 6 33.6 RP9 RPGR
6 retinitis pigmentosa 25 33.6 EYS RP9
7 retinitis pigmentosa 10 33.6 IMPDH1 RHO RP9
8 retinitis pigmentosa 1 33.5 PRPH2 RHO RP1 RP1L1
9 retinitis pigmentosa 18 33.3 IMPDH1 PRPF3 RP9
10 peripheral retinal degeneration 33.3 PRPH2 RPGR
11 retinal degeneration 33.3 PRPH2 RHO RLBP1 RP2 RPGR RPGRIP1
12 retinitis pigmentosa 13 33.2 IMPDH1 PRPF3 RP9 RPGR
13 fundus albipunctatus 33.2 PRPH2 RHO RLBP1
14 retinal disease 32.9 IMPDH1 PRPF3 PRPH2 RHO RLBP1 RPGR
15 cone-rod dystrophy 2 32.9 CERKL FAM161A PRPH2 RHO RPGR RPGRIP1
16 leber congenital amaurosis 32.5 IMPDH1 PRPH2 RHO RP2 RPGR RPGRIP1
17 cone dystrophy 32.5 RHO RLBP1 RPGR
18 stargardt disease 32.1 EYS PRPH2 RHO RPGR
19 usher syndrome, type iid 32.0 RHO RPGR
20 fundus dystrophy 31.3 ABHD12 CERKL EYS PRPH2 RHO RLBP1
21 retinitis pigmentosa 30.6 ABHD12 CERKL EYS FAM161A FLVCR1 IMPDH1
22 bestrophinopathy 29.8 PRPH2 RLBP1
23 stargardt macular degeneration 29.7 PRPH2 RHO
24 retinal detachment 12.5
25 retinitis pigmentosa 3 12.5
26 retinitis pigmentosa 27 12.4
27 retinitis pigmentosa 12 12.4
28 doyne honeycomb retinal dystrophy 12.4
29 central retinal vein occlusion 12.4
30 retinitis pigmentosa 11 12.4
31 retinitis pigmentosa 4 12.4
32 retinitis pigmentosa 17 12.4
33 retinitis pigmentosa 30 12.4
34 late-onset retinal degeneration 12.3
35 retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities 12.3
36 retinitis pigmentosa 51 12.3
37 retinitis pigmentosa 55 12.3
38 retinitis pigmentosa 45 12.3
39 central retinal artery occlusion 12.3
40 retinal vascular occlusion 12.3
41 cytomegalovirus retinitis 12.3
42 neuropathy, ataxia, and retinitis pigmentosa 12.3
43 infantile cerebellar-retinal degeneration 12.3
44 retinitis pigmentosa 50 12.3
45 posterior column ataxia with retinitis pigmentosa 12.3
46 retinal arteries, tortuosity of 12.3
47 retinitis pigmentosa 41 12.3
48 retinitis pigmentosa 67 12.3
49 vasculopathy, retinal, with cerebral leukodystrophy 12.3
50 retinitis pigmentosa 38 12.3

Graphical network of the top 20 diseases related to Retinitis:



Diseases related to Retinitis

Symptoms & Phenotypes for Retinitis

MGI Mouse Phenotypes related to Retinitis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 nervous system MP:0003631 9.9 ABHD12 FAM161A PRPH2 RHO RLBP1 RP1
2 vision/eye MP:0005391 9.47 ABHD12 CERKL FAM161A IMPDH1 PRPF3 PRPH2
3 pigmentation MP:0001186 9.43 PRPF3 PRPH2 RHO RLBP1 RPGR SEMA4A

Drugs & Therapeutics for Retinitis

Drugs for Retinitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 237)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cidofovir Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 113852-37-2 60613
2
Ganciclovir Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 82410-32-0 3454
3
Foscarnet Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 63585-09-1, 4428-95-9 3415
4
Probenecid Approved, Investigational Phase 4,Phase 2,Phase 1,Not Applicable 57-66-9 4911
5
Phosphonoacetic Acid Experimental Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 4408-78-0 546
6 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
7 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
8 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
9 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
10 Ganciclovir triphosphate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
11 Reverse Transcriptase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
12 Anti-Retroviral Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
13 Renal Agents Phase 4,Phase 2,Phase 1,Not Applicable
14
Valganciclovir Approved, Investigational Phase 3,Phase 2,Not Applicable 175865-60-8 64147
15
Eplerenone Approved Phase 2, Phase 3 107724-20-9 443872 150310
16
Spironolactone Approved Phase 2, Phase 3,Phase 1 52-01-7, 1952-01-7 5833
17
Prednisolone phosphate Approved, Vet_approved Phase 3 302-25-0
18
Methylprednisolone Approved, Vet_approved Phase 3 83-43-2 6741
19
leucovorin Approved Phase 3,Phase 1,Phase 2 58-05-9 6006 143
20
Clindamycin Approved, Vet_approved Phase 3 18323-44-9 29029
21
Prednisolone Approved, Vet_approved Phase 3 50-24-8 5755
22
Methylprednisolone hemisuccinate Approved Phase 3 2921-57-5
23
Sulfadiazine Approved, Investigational, Vet_approved Phase 3 68-35-9 5215
24
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2 50-02-2 5743
25
Pyrimethamine Approved, Investigational, Vet_approved Phase 3 58-14-0 4993
26
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 3,Phase 2 1177-87-3
27
Tocopherol Approved, Investigational Phase 3 1406-66-2 14986
28
Acyclovir Approved Phase 3,Not Applicable 59277-89-3 2022
29
Celecoxib Approved, Investigational Phase 3 169590-42-5 2662
30
Beta carotene Approved, Nutraceutical Phase 2, Phase 3,Phase 1 7235-40-7
31
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 1,Phase 2,Early Phase 1 59-30-3 6037
32
Vitamin D Approved, Nutraceutical, Vet_approved Phase 3 1406-16-2
33
Vitamin A Approved, Nutraceutical, Vet_approved Phase 3,Phase 1 11103-57-4, 68-26-8 445354
34
Lutein Approved, Investigational, Nutraceutical Phase 3,Phase 1,Phase 2 127-40-2 6433159
35
Vitamin E Approved, Nutraceutical, Vet_approved Phase 3 59-02-9 14985
36
Prednisolone hemisuccinate Experimental Phase 3 2920-86-7
37 Tocotrienol Investigational Phase 3 6829-55-6
38 Vitamins Phase 2, Phase 3,Phase 3,Phase 1,Early Phase 1
39 Trace Elements Phase 2, Phase 3,Phase 3,Phase 1,Early Phase 1
40 Antioxidants Phase 2, Phase 3,Phase 3,Phase 1
41 Carotenoids Phase 2, Phase 3,Phase 1
42 Protective Agents Phase 2, Phase 3,Phase 3,Phase 1
43 Provitamins Phase 2, Phase 3,Phase 1
44 Micronutrients Phase 2, Phase 3,Phase 3,Phase 1,Early Phase 1
45 Diuretics, Potassium Sparing Phase 2, Phase 3,Phase 1
46 Hormone Antagonists Phase 2, Phase 3,Phase 3,Phase 1
47 diuretics Phase 2, Phase 3,Phase 1
48 Mineralocorticoids Phase 2, Phase 3,Phase 1
49 Hormones Phase 2, Phase 3,Phase 3,Phase 1
50 Mineralocorticoid Receptor Antagonists Phase 2, Phase 3,Phase 1

Interventional clinical trials:

(show top 50) (show all 256)
# Name Status NCT ID Phase Drugs
1 Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis Completed NCT00000894 Phase 4 Cidofovir;Probenecid;Ganciclovir
2 The Role of Capsular Tension Ring (CTR) in Anterior Capsular Contraction Completed NCT00717080 Phase 4
3 A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium) Completed NCT00002125 Phase 4 Foscarnet sodium
4 Pharmacokinetics of Cidofovir During Continuous Venovenous Hemofiltration Completed NCT01866397 Phase 4
5 Use of Cidofovir for Recurrent Respiratory Papillomatosis Completed NCT00205374 Phase 4 Cidofovir;Placebo
6 Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection Unknown status NCT00017784 Phase 3 Valganciclovir
7 The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil Unknown status NCT01680510 Phase 2, Phase 3
8 A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy Unknown status NCT02215330 Phase 2, Phase 3 Eplerenone;Maltodextrin
9 To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis Unknown status NCT00372294 Phase 3 pyrimethamine-sulfadiazine + prednisolone;Clindamycin+Dexamethasone
10 Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A Completed NCT00346333 Phase 3 Lutein
11 Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT) Completed NCT00000142 Phase 2, Phase 3 Cidofovir
12 Randomized Trial for Retinitis Pigmentosa Completed NCT00000116 Phase 3 Vitamin A;Nutritional Supplement
13 Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT) Completed NCT00000135 Phase 2, Phase 3 MSL-109
14 A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS Completed NCT00000688 Phase 3 Ganciclovir
15 Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT) Completed NCT00000134 Phase 3 Ganciclovir;Foscarnet
16 A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis Completed NCT00000698 Phase 3 Ganciclovir
17 Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT) Completed NCT00000136 Phase 3 Foscarnet;Ganciclovir
18 Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis Completed NCT00002070 Phase 3 Sargramostim;Ganciclovir
19 Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa Completed NCT00000114 Phase 3 Vitamin E;Vitamin A
20 Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT) Completed NCT00000143 Phase 3 Cidofovir intravenous
21 Ganciclovir Implant Study for Cytomegalovirus Retinitis Completed NCT00000118 Phase 3
22 A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes Completed NCT00002377 Phase 3 Valganciclovir;Ganciclovir
23 Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT) Completed NCT00330018 Phase 3 Valganciclovir;Acyclovir
24 Ozurdex for Macular Edema Post Membrane Peeling Completed NCT01273727 Phase 2, Phase 3 Dexamethasone;dexamethasone
25 Laser and Medical Treatment of Diabetic Macular Edema Completed NCT00050479 Phase 3 Celecoxib (Celebrex)
26 Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001) Completed NCT02137772 Phase 3 Letermovir;Placebo
27 Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Patients With Moderate to Severe Obesity Recruiting NCT03746522 Phase 3 Setmelanotide;Placebos
28 Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity Recruiting NCT03013543 Phase 2, Phase 3 Setmelanotide
29 Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis Active, not recruiting NCT00999609 Phase 3
30 Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome Enrolling by invitation NCT03184584 Phase 2, Phase 3 PBI-4050
31 Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes Not yet recruiting NCT03586284 Phase 2, Phase 3 Valganciclovir Hydrochloride;Ganciclovir Sodium;Placebo Oral Tablet;Topical placebo
32 Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa Terminated NCT01786395 Phase 3 UF-021;Placebo
33 Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) Study Unknown status NCT02661711 Phase 2 Aflibercept
34 Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa Unknown status NCT01914913 Phase 1, Phase 2
35 Intravitreal Dexamethasone Implant in Retinitis Pigmentosa-related Macular Edema- a Retrospective Study Unknown status NCT02804360 Phase 2
36 Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa Completed NCT01560715 Phase 2
37 Trial of Oral Valproic Acid for Retinitis Pigmentosa Completed NCT01233609 Phase 2 Valproic Acid;Placebo
38 Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosa Completed NCT02140164 Phase 1, Phase 2 Minocycline
39 A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa Completed NCT00447993 Phase 2 NT-501;NT-501
40 Safety Study in Retinal Transplantation for Retinitis Pigmentosa. Completed NCT00345917 Phase 2
41 A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa Completed NCT00447980 Phase 2 NT-501;NT-501
42 Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa Completed NCT02320812 Phase 1, Phase 2
43 CMV Retinitis Retreatment Trial Completed NCT00000766 Phase 2 Foscarnet sodium;Ganciclovir
44 Effects of Lutein in Retinitis Pigmentosa Completed NCT00029289 Phase 1, Phase 2 Lutein (10 or 30 mg/day) capsules
45 Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema Completed NCT02609165 Phase 2 rhNGF 180 µg/ml eye drops solution;vehicle eye drops
46 A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR ) Completed NCT00002156 Phase 2 Fomivirsen sodium;Ganciclovir
47 A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis Completed NCT00002169 Phase 2 Nelfinavir mesylate
48 DHA and X-Linked Retinitis Pigmentosa Completed NCT00100230 Phase 2 docosahexaenoic acid OR corn/soy oil placebo
49 A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure Completed NCT00000691 Phase 2 Foscarnet sodium
50 A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP) Completed NCT02110225 Phase 1, Phase 2 rhNGF 60 µg/ml eye drops solution;rhNGF 180 µg/ml eye drops solution;Placebo

Search NIH Clinical Center for Retinitis

Genetic Tests for Retinitis

Anatomical Context for Retinitis

MalaCards organs/tissues related to Retinitis:

41
Eye, Bone, Retina, Testes, T Cells, Bone Marrow, Kidney

Publications for Retinitis

Articles related to Retinitis:

(show top 50) (show all 3406)
# Title Authors Year
1
Drosophila melanogaster: A Valuable Genetic Model Organism to Elucidate the Biology of Retinitis Pigmentosa. ( 30324448 )
2019
2
Two-year progression analysis of RPE65 autosomal dominant retinitis pigmentosa. ( 29947567 )
2018
3
Spectral domain optical coherence tomography and fundus autofluorescence findings in cytomegalovirus retinitis in HIV-infected patients. ( 29445945 )
2018
4
Characterization of Retinitis Pigmentosa Using Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO). ( 29946494 )
2018
5
Comparison of 5-year progression of retinitis pigmentosa involving the posterior pole among siblings by means of SD-OCT: a retrospective study. ( 29940899 )
2018
6
Quantification of Macular Microvascular Changes in Patients With Retinitis Pigmentosa Using Optical Coherence Tomography Angiography. ( 29365150 )
2018
7
Optical coherence tomography angiography of the macular microvasculature changes in retinitis pigmentosa. ( 28561452 )
2018
8
Olfactory Dysfunction in Patients With CNGB1-Associated Retinitis Pigmentosa. ( 29800053 )
2018
9
Phenotypic expansion and progression of SPATA7-associated retinitis pigmentosa. ( 29411205 )
2018
10
Cytomegalovirus retinitis before and after treatment. ( 29776766 )
2018
11
Toxoplasma gondii bradyzoites and tachyzoites isolation from vitreous of atypical necrotizing retinitis. ( 29904801 )
2018
12
Epidemic Retinitis. ( 29370564 )
2018
13
Patients and animal models of CNGI^1-deficient retinitis pigmentosa support gene augmentation approach. ( 29202463 )
2018
14
Simultaneous Presence of Macular Corneal Dystrophy and Retinitis Pigmentosa in Three Members of a Family. ( 29749994 )
2018
15
Targeted Next-Generation Sequencing Reveals Novel RP1 Mutations in Autosomal Recessive Retinitis Pigmentosa. ( 29425069 )
2018
16
Aerobic Glycolysis Is Essential for Normal Rod Function and Controls Secondary Cone Death in Retinitis Pigmentosa. ( 29847794 )
2018
17
Myoclonus epilepsy, retinitis pigmentosa, leukoencephalopathy and cerebral calcifications associated with a novel m.5513G>A mutation in the MT-TW gene. ( 29625105 )
2018
18
The first case of Trypanosoma cruzi-associated retinitis in an immunocompromised host diagnosed by pan-organism PCR. ( 29385482 )
2018
19
Coping strategies, vision-related quality of life, and emotional health in managing retinitis pigmentosa: a survey study. ( 29378559 )
2018
20
A novel mutation in RDH5 gene causes retinitis pigmentosa in consanguineous Pakistani family. ( 29892959 )
2018
21
Ultra-widefield imaging in Coats'-type retinitis pigmentosa. ( 29941749 )
2018
22
Targeted Next Generation Sequencing Revealed Novel PRPF31 Mutations in Autosomal Dominant Retinitis Pigmentosa. ( 29957067 )
2018
23
Correlation between aqueous flare and residual visual field area in retinitis pigmentosa. ( 29858180 )
2018
24
Acute Progressive Visual Loss in a Case of Acute Myeloid Leukemia: Challenges in the Utility of Molecular Tests in Early Diagnose of Cytomegalovirus Retinitis. ( 29560000 )
2018
25
Suppressor of Cytokine Signaling (SOCS)1 and SOCS3 Are Stimulated Within the Eye During Experimental Murine Cytomegalovirus Retinitis in Mice With Retrovirus-Induced Immunosuppression. ( 29976680 )
2018
26
Mutation screening of the USH2A gene in retinitis pigmentosa and USHER patients in a Han Chinese population. ( 29899460 )
2018
27
Misdiagnosis of X-linked retinitis pigmentosa in a choroideremia patient with heavily pigmented fundi. ( 29377744 )
2018
28
Variability in clinical phenotypes of PRPF8-linked autosomal dominant retinitis pigmentosa correlates with differential PRPF8/SNRNP200 interactions. ( 29087248 )
2018
29
A novel LRAT mutation affecting splicing in a family with early onset retinitis pigmentosa. ( 29973277 )
2018
30
Retinal Anatomy and Electrode Array Position in Retinitis Pigmentosa Patients after Argus II Implantation: an International Study. ( 29940167 )
2018
31
Bilateral Asymptomatic Cryptococcal Retinitis without Choroiditis or Vitritis. ( 29566868 )
2018
32
highroad Is a Carboxypetidase Induced by Retinoids to Clear Mutant Rhodopsin-1 in Drosophila Retinitis Pigmentosa Models. ( 29425495 )
2018
33
Expression Profiling Analysis Reveals Key MicroRNA-mRNA Interactions in Early Retinal Degeneration in Retinitis Pigmentosa. ( 29847644 )
2018
34
Eplerenone, a new treatment for an old problem: Retinitis pigmentosa with recalcitrant macular edema. ( 28624313 )
2018
35
RAPIDLY PROGRESSIVE NEOVASCULAR GLAUCOMA FROM CYTOMEGALOVIRUS RETINITIS IN A NON-HUMAN IMMUNODEFICIENCY VIRUS PATIENT. ( 29533389 )
2018
36
Bilateral arterial occlusions masking retinitis in a HIV-positive male. ( 29380798 )
2018
37
Toward the Mutational Landscape of Autosomal Dominant Retinitis Pigmentosa: A Comprehensive Analysis of 258 Spanish Families. ( 29847639 )
2018
38
A splicing mutation in aryl hydrocarbon receptor associated with retinitis pigmentosa. ( 29931334 )
2018
39
Concise Review: Human Induced Pluripotent Stem Cell Models of Retinitis Pigmentosa. ( 29345014 )
2018
40
AAV Gene Augmentation Therapy for CRB1-Associated Retinitis Pigmentosa. ( 29188511 )
2018
41
Intraobserver Repeatability and Interobserver Reproducibility of Ellipsoid Zone Measurements in Retinitis Pigmentosa. ( 29881650 )
2018
42
Discovery of a Cynomolgus Monkey Family With Retinitis Pigmentosa. ( 29411010 )
2018
43
Design and Development of AAV-based Gene Supplementation Therapies for Achromatopsia and Retinitis Pigmentosa. ( 29188504 )
2018
44
Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial. ( 29879277 )
2018
45
Cytomegalovirus retinitis, in a diabetic immunocompetent patient, after intravitreal ranibizumab injection. ( 29747535 )
2018
46
Nonclinical Safety Evaluation of scAAV8-<i>RLBP1</i>for Treatment of<i>RLBP1</i>Retinitis Pigmentosa. ( 29359172 )
2018
47
A novel mutation in<i>PRPF31</i>, causative of autosomal dominant retinitis pigmentosa, using the BGISEQ-500 sequencer. ( 29375987 )
2018
48
Rasagiline delays retinal degeneration in a mouse model of retinitis pigmentosa via modulation of Bax/Bcl-2 expression. ( 29372592 )
2018
49
Methodological Insights for Randomized Clinical Trials of Retinitis Pigmentosa: Lessons Learned From a Trial of Valproic Acid. ( 29879289 )
2018
50
Application of empirical Bayes methods to predict the rate of decline in ERG at the individual level among patients with retinitis pigmentosa. ( 29855067 )
2018

Variations for Retinitis

Expression for Retinitis

Search GEO for disease gene expression data for Retinitis.

Pathways for Retinitis

GO Terms for Retinitis

Cellular components related to Retinitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell projection GO:0042995 9.91 FAM161A RHO RP1 RP1L1 RP2 RPGR
2 cilium GO:0005929 9.73 FAM161A RP1 RP1L1 RP2 RPGR RPGRIP1
3 ciliary basal body GO:0036064 9.62 FAM161A RP2 RPGR TOPORS
4 axoneme GO:0005930 9.58 RP1 RP1L1 RPGRIP1
5 photoreceptor inner segment GO:0001917 9.46 CERKL FAM161A RHO RP1
6 photoreceptor connecting cilium GO:0032391 9.35 FAM161A RP1 RP1L1 RPGRIP1 TOPORS
7 photoreceptor outer segment GO:0001750 9.1 CERKL PRPH2 RHO RP1 RP1L1 RPGR

Biological processes related to Retinitis according to GeneCards Suite gene sharing:

(show all 12)
# Name GO ID Score Top Affiliating Genes
1 response to stimulus GO:0050896 9.76 EYS FAM161A RHO RLBP1 RP1 RP1L1
2 cell projection organization GO:0030030 9.67 FAM161A RP1 RP1L1 RPGR
3 axoneme assembly GO:0035082 9.51 RP1 RP1L1
4 cellular response to light stimulus GO:0071482 9.49 RHO RP1
5 photoreceptor cell outer segment organization GO:0035845 9.48 RP1 TOPORS
6 retinal cone cell development GO:0046549 9.46 RP1 TOPORS
7 retinal rod cell development GO:0046548 9.43 RP1 TOPORS
8 photoreceptor cell maintenance GO:0045494 9.43 RHO RP1 RP1L1
9 phototransduction, visible light GO:0007603 9.4 RHO RP1
10 retina development in camera-type eye GO:0060041 9.35 PRPH2 RHO RP1 RP1L1 RPGRIP1
11 photoreceptor cell development GO:0042461 9.32 RP1 RP1L1
12 visual perception GO:0007601 9.32 EYS FAM161A PRPH2 RHO RLBP1 RP1

Molecular functions related to Retinitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 11-cis retinal binding GO:0005502 8.62 RHO RLBP1

Sources for Retinitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....